Clinical Trials Logo

Colorectal Cancer clinical trials

View clinical trials related to Colorectal Cancer.

Filter by:

NCT ID: NCT02388256 Completed - Colorectal Cancer Clinical Trials

Acupuncture for Enhanced Recovery After Surgery in Patients Undergoing Laparoscopic Colorectal Cancer Resection

Start date: March 2015
Phase: N/A
Study type: Interventional

Background: Patients who undergo laparoscopic surgical resection of colorectal cancer may experience various post-operative symptoms (e.g., pain, nausea and vomiting, and anxiety) and limitation of daily activities (e.g., walking capacity). There is also a risk of post-operative complications and a prolonged hospital stay due to complications. Patients who underwent surgical resection may have experienced chronic pain, anxiety/depression, or diminished quality of life. The physical, psychological, and functional aspects of patients' disorders imply the necessity of multidisciplinary care, including complementary or traditional medicines such as acupuncture. This study aims to assess whether acupuncture treatment, combined with an enhanced recovery program after surgery in an inpatient care setting is effective than only an enhanced recovery program after surgery. Objective: To assess the effectiveness and safety of acupuncture combined with an enhanced recovery program after surgery to reduce postoperative symptoms and improve functional recovery and the patients' quality of life.

NCT ID: NCT02387268 Completed - Clinical trials for Colorectal Cancer (CRC) Screening

Evaluation of the Performance of the CleanC System-Israel

Start date: May 2015
Phase: N/A
Study type: Interventional

The Motus GI Colon Cleansing device is intended to facilitate intra-procedural cleaning of a poorly prepared colon by irrigating the colon and evacuating the irrigation fluid and feces.

NCT ID: NCT02386826 Completed - Colorectal Cancer Clinical Trials

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

Start date: September 22, 2015
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine whether the combination of two agents, INC280 and bevacizumab, is safe and effective when administered to patients with Glioblastoma Multiforme (GBM) who have progressed after receiving prior therapy or who have unresectable GBM.

NCT ID: NCT02386618 Completed - Colorectal Cancer Clinical Trials

Endoscopic Treatment for Local Residual Neoplasia

Start date: October 2013
Phase: N/A
Study type: Interventional

Endoscopic mucosal resection (EMR) is considered to be a gold standard of therapy of colorectal lateral spreading tumors (LST) without significant risk for lymphatic spread. According to the investigators previous study, local residual neoplasia (LRN) after conventional endoscopic mucosal resection (EMR)occurs in up to 21% of cases. Endoscopic therapy of LRN was not sufficient in 53 % and has not been standardized yet.

NCT ID: NCT02375672 Completed - Colorectal Cancer Clinical Trials

Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer

Start date: May 28, 2015
Phase: Phase 2
Study type: Interventional

This is a multi-institutional, single arm, open-label, phase II study, including a safety run-in cohort. No randomization or blinding involved.

NCT ID: NCT02374255 Completed - Colorectal Cancer Clinical Trials

Improving Goals of Care Discussion in Advanced Cancer Patients

Start date: March 15, 2016
Phase: N/A
Study type: Interventional

The goal of this study is to increase and improve Goals of Care discussions for advanced cancer patients by training medical oncologists to conduct these discussions. The investigators will evaluate the GoC discussion's effects on patient satisfaction, receipt of treatment in line with preferences, use of aggressive treatment, and oncologist communication skill.

NCT ID: NCT02372500 Not yet recruiting - Colorectal Cancer Clinical Trials

Trial of Chewing Gum to Reduce Post Operative Ileus in Elective Colorectal Surgery

Start date: March 2015
Phase: N/A
Study type: Interventional

It is unknown whether post operative chewing gum will reduce post operative ileus. This study is a randomised controlled trial that will determine whether chewing gum three times a day following surgery will reduce post operative ileus. Time to passage of flatus will be used to determine that incidence of ileus.

NCT ID: NCT02367001 Completed - Breast Cancer Clinical Trials

Randomized Trial Evaluating the Effectiveness of the General Practitioner Involvement in Cancer Screening Invitations

GPs
Start date: February 2014
Phase: N/A
Study type: Interventional

Our goal is to evaluate, in France, the effectiveness (in terms of participation) of the general practitioner involvement (signature) and a more personalized communication in invitation letters to organized screening of breast, colorectal and cervical cancers. The hypothesis on which this project is based is that communication is probably more effective if the "receiver" feels personally targeted by invitation letters (Dear Martin, I am writing ...) and if he knows "the issuer "(his general practitioner rather an unknown person).

NCT ID: NCT02364154 Completed - Colorectal Cancer Clinical Trials

Colorectal Cancer Detected by 1H-NMR Spectroscopy

BIOCOR
Start date: December 2014
Phase:
Study type: Observational [Patient Registry]

The hypothesis of the present study is that metabolic phenotyping of blood plasma allows to (i) discriminate between colorectal cancer patients and control subjects and (ii) identify new biomarkers for colorectal cancer. In order to test this hypothesis, the investigators will apply proton nuclear magnetic resonance (1H-NMR) spectroscopy to perform metabolic phenotyping of blood plasma in 50 colorectal cancer patients and 50 control subjects. Multivariate statistics will be performed to assess the discriminative power of the applied methodology in distinguishing between both groups and to identify metabolites with potential as biomarkers for colorectal cancer.

NCT ID: NCT02360605 Completed - Colorectal Cancer Clinical Trials

Health Literacy Interventions to Overcome Disparities in CRC Screening

Start date: February 2015
Phase: N/A
Study type: Interventional

In the proposed project the investigators will evaluate two different follow-up approaches to improve low income patients' completion of initial and annual colorectal cancer (CRC) screening using the Fecal Immunochemical Test (FIT), the most sensitive FOBT. The purpose of this study is to compare the effectiveness of two distinct follow-up strategies to promote CRC screening: a prevention coordinator (PC) approach vs. an automated telephone reminder (ATR) system. The investigators will adapt a successful intervention tested in the Health Literacy and Cancer Screening Project by adding a follow-up strategy to the health literacy intervention. Specific Aims: The investigators Primary Aims are to: 1. Compare the effectiveness of the PC and ATR strategies to improve initial and repeat CRC screening. 2. Compare the cost effectiveness of the PC and ATR strategies for initial and repeat CRC screening. The investigators Secondary Aims are to: 3. Conduct a process evaluation of both follow-up strategies to investigate implementation and barriers 4. Determine if the effects of either strategy vary by patients' literacy skills. 5. Explore patient characteristics associated with CRC screening knowledge, beliefs, self-efficacy, and compliance over time between study arms.